Nephris
The startup develops targeted therapies for diabetic nephropathy, focusing on mechanisms that enhance kidney function and slow disease progression. By advancing research on diabetic kidney disease, the company provides the scientific community with new therapeutic targets to improve patient outcomes.
Traction –/10
Milan, Italy · HQ
- Biotechnology
Updated 5 months ago
Funding
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops targeted therapies for diabetic nephropathy, focusing on mechanisms that enhance kidney function and slow disease progression. By advancing research on diabetic kidney disease, the company provides the scientific community with new therapeutic targets to improve patient outcomes.